Cecília Roteli-Martins

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

Diane M. Harper, Eduardo L. Franco, Cosette M. Wheeler et al. · The Lancet · 2004 · 1.6K citations

Vaccination, Vaccine Safety, Vaccine Development +6

Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

Diane M. Harper, Eduardo L. Franco, Cosette M. Wheeler et al. · The Lancet · 2006 · 1.6K citations · Full text

Vaccination, Vaccinology, Vaccine Development +8

Efficacy of a Bivalent L1 Virus-Like Particle Vaccine in Prevention of Infection With Human Papillomavirus Types 16 and 18 in Young Women: A Randomized Trial

Diane M. Harper, Eduardo L. Franco, Cosette M. Wheeler et al. · Obstetrical & Gynecological Survey · 2005 · 247 citations

Immunology, Gynecology, Hpv Infection +27

Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine

Paulo Naud, Cecília Roteli-Martins, Newton Sérgio de Carvalho et al. · Human Vaccines & Immunotherapeutics · 2014 · 245 citations · Full text

Sustained immunogenicity and efficacy of the HPV-16/18 AS04-adjuvanted vaccine

Cecília Roteli-Martins, Paulo Naud, P. De Borba et al. · Human Vaccines & Immunotherapeutics · 2012 · 188 citations · Full text